Common Adverse Events (Reported in Clinical Trials): Gastrointestinal symptoms are the most common, occurring in up to 44% of patients in some trials
Pros Mature calorie, macro, and food database with barcode and meal scan Meal planning, recipes, and grocery lists on premium tiers Exercise logging and connected fitness apps GLP-1 medication tracking and reminders now included Cons General food diary first injection sites, symptom severity, and medication-level graphs are not the core design 7
In most cases, retatrutide is something to watch, not something to start today in normal practice
So the potential for growth is actually similar again as a percentage
This study focuses on the potential of 6-thio-2-deoxyguanosine (6-thio-dG) and its dimer form to inhibit GSTP1, leveraging both experimental and computational techniques